This compound is a protected amino acid derivative featuring a fluorenylmethoxycarbonyl (Fmoc) protecting group and a side-chain modification with a hydroxy-dimethylcyclohexenone moiety. It is primarily used as a building block in solid-phase peptide synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 204777-78-6
N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-2,4-diaminobutyric acid
pharmaceutical intermediate
Fmoc-D-Lys(Dde)-OH
pharmaceutical intermediate
N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl]-L-lysine
pharmaceutical intermediate
(2S)-4-[[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid
pharmaceutical intermediate
N-Cbz-O-tert-butyl-L-serine
pharmaceutical intermediate
N-(Benzyloxycarbonyl)-L-tyrosine methyl ester
pharmaceutical intermediate
Benzyl (2S)-6-amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoate;hydrochloride
pharmaceutical intermediate
Cbz-D-(-)-Phenylglycine
pharmaceutical intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)-3-methylbutylidene]amino]hexanoic acid
LHJJUCZESVFWSO-MHZLTWQESA-N
CC(C)CC(=NCCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C4=C(CC(CC4=O)(C)C)O